 Connection
Timothy McKinsey to Cardiovascular Agents
This is a "connection" page, showing publications Timothy McKinsey has written about Cardiovascular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.570 |
|
|
|
-
McKinsey TA, Kass DA. Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat Rev Drug Discov. 2007 Aug; 6(8):617-35.
Score: 0.238
-
Tocchetti CG, González A, Backs J, Pollesello P, Rainer PP, Schiattarella GG, Bellin M, Begley G, Bock Marquette I, Balligand JL, Falcao-Pires I, Gorczynski R, Hirsch E, Hulot JS, Klebl B, Lyon AR, Maack C, McKinsey TA, Müller OJ, Lunde I, Montgomery R, Vergaro G, Bayes-Genis A, Thum T, van der Meer P, Van Laake L, Ruschitzka F, Seferovic P, Coats AJ, Metra M, Rosano G, Van Linthout S, de Boer RA. How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025 Aug; 27(8):1379-1392.
Score: 0.206
-
McKinsey TA. The biology and therapeutic implications of HDACs in the heart. Handb Exp Pharmacol. 2011; 206:57-78.
Score: 0.076
-
Altman NL, Gill EA, Kahwash R, Meyer LK, Wagner JA, Karimpour-Fard A, Berning AA, Minobe WA, Carroll IA, Jonas ER, Slavov D, Emani S, Abraham WT, Gollah AR, Ellis SL, Taylor MRG, Graw SL, Mestroni L, McKinsey TA, Buttrick PM, Kao DP, Bristow MR. Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated Cardiomyopathy. Circ Heart Fail. 2025 Apr; 18(4):e012484.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|